Cumberland Pharmaceuticals's top three insider shareholders as of September 29, 2026 are A J Kazimi (Chairman And Ceo, 5.70Mn shares), Kenneth Krogulski (Director, 302.34K shares), Martin E Cearnal (Sr Vp/Chief Commercial Officer, 163.47K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | A J Kazimi | Chairman And Ceo | 5,695,310 | 0 | 5,695,310 | 86.0% | 18 Mar, 2026 |
| 2 | Kenneth Krogulski | Director | 302,338 | 0 | 302,338 | 4.6% | 20 Mar, 2026 |
| 3 | Martin E Cearnal | Sr Vp/Chief Commercial Officer | 163,473 | 0 | 163,473 | 2.5% | 29 Apr, 2022 |
| 4 | Leo Pavliv | Svp And Chief Development Off. | 129,618 | 0 | 129,618 | 2.0% | 01 Jul, 2022 |
| 5 | Joey A Jacobs | Director | 98,415 | 0 | 98,415 | 1.5% | 21 Mar, 2023 |
| 6 | Joseph C Galante | Director | 63,656 | 0 | 63,656 | 1.0% | 20 Mar, 2026 |
| 7 | James Jones | Director | 46,863 | 0 | 46,863 | 0.7% | 20 Mar, 2026 |
| 8 | James L Herman | Vp And Chief Compliance Office | 38,255 | 0 | 38,255 | 0.6% | 26 Mar, 2024 |
| 9 | Caroline Young | Director | 35,109 | 0 | 35,109 | 0.5% | 20 Mar, 2026 |
| 10 | John M. Hamm | Vp Chief Financial Officer | 20,073 | 0 | 20,073 | 0.3% | 18 Mar, 2025 |
| 11 | Todd M. Anthony | Vice Pres Organizational Dev | 16,328 | 0 | 16,328 | 0.2% | 26 Mar, 2024 |
| 12 | Martin S Jr Brown | Director | 10,300 | 0 | 10,300 | 0.2% | 20 Mar, 2026 |
| 13 | Chris T. Bitterman | Vice Pres Sales Marketing | 4,683 | 0 | 4,683 | 0.1% | 26 Mar, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 18 Mar, 2026 | Kenneth Krogulski | Director | Acquired A | 1,800 | $2.80 | $5.04K | 298,338 | Direct |
| 18 Mar, 2026 | James L Herman | Vp And Chief Compliance Office | Acquired A | 2,500 | $2.80 | $7.00K | 21,000 | Direct |
| 18 Mar, 2026 | Caroline Young | Director | Acquired A | 1,800 | $2.80 | $5.04K | 35,109 | Direct |
| 18 Mar, 2026 | Chris T. Bitterman | Vice Pres Sales Marketing | Acquired A | 3,000 | $2.80 | $8.40K | 19,000 | Direct |
| 18 Mar, 2026 | James Jones | Director | Acquired A | 1,800 | $2.80 | $5.04K | 46,863 | Direct |
| 18 Mar, 2026 | A J Kazimi | Chairman And Ceo | Acquired A | 100,000 | $2.80 | $280.00K | 568,000 | Direct |
| 18 Mar, 2026 | John M. Hamm | Vp Chief Financial Officer | Acquired A | 3,000 | $2.80 | $8.40K | 18,250 | Direct |
| 18 Mar, 2026 | Martin S Jr Brown | Director | Acquired A | 1,800 | $2.80 | $5.04K | 10,300 | Direct |
| 18 Mar, 2026 | Joseph C Galante | Director | Acquired A | 1,800 | $2.80 | $5.04K | 63,656 | Direct |
| 18 Mar, 2026 | Todd M. Anthony | Vice Pres Organizational Dev | Acquired A | 3,000 | $2.80 | $8.40K | 21,000 | Direct |
| 18 Mar, 2026 | Kenneth Krogulski | Director | Acquired A | 4,000 | $2.80 | $11.20K | 302,338 | Direct |
| 16 Mar, 2026 | A J Kazimi | Chairman And Ceo | Disposed F | 5,845 | $3.06 | $17.89K | 5,695,310 | Direct |
| 01 Dec, 2025 | James Jones | Director | Acquired L | 18 | $2.36 | $42 | 44,811 | Direct |
| 01 Dec, 2025 | Caroline Young | Director | Acquired L | 4 | $2.36 | $9 | 33,247 | Direct |
| 01 Dec, 2025 | A J Kazimi | Chairman And Ceo | Acquired L | 18 | $2.36 | $42 | 5,700,903 | Direct |
| 01 Dec, 2025 | Kenneth Krogulski | Director | Acquired L | 124 | $2.36 | $293 | 294,746 | Direct |
| 02 Dec, 2025 | A J Kazimi | Chairman And Ceo | Acquired L | 18 | $2.24 | $40 | 5,700,921 | Direct |
| 02 Dec, 2025 | Kenneth Krogulski | Director | Acquired L | 124 | $2.24 | $278 | 294,870 | Direct |
| 02 Dec, 2025 | Caroline Young | Director | Acquired L | 4 | $2.24 | $9 | 33,251 | Direct |
| 02 Dec, 2025 | James Jones | Director | Acquired L | 18 | $2.24 | $40 | 44,829 | Direct |